Download Free Zika Virus Impact Diagnosis Control And Models Book in PDF and EPUB Free Download. You can read online Zika Virus Impact Diagnosis Control And Models and write the review.

Zika Virus Impact, Diagnosis, Control, and Models: Volume Two: The Neuroscience of Zika examines diagnosis, vaccines, and potential therapy methods for Zika virus syndrome. The book also details the neuroscience of Guillain-Barré syndrome, its effects and neuromuscular rehabilitation. It is designed to help readers better understand detection, therapies for Zika virus, preventative vaccines, diagnosis and associated microcephaly. Chapters on models enable further research and understanding. This book has applicability for neuroscientists, neurologists, virologists and anyone working to better understand the evolution and pathogenesis of Zika virus-related conditions. - Provides a broad range of topics related to the neuroscience of Zika, including its diagnosis, vaccines and therapy - Contains chapter abstracts, key facts, a dictionary of terms and summary points to aid in understanding - Discusses novel and non-pharmacological therapies, Guillain-Barré Syndrome and vaccine development - Features chapters on rat, mouse, and guinea pig models of Zika and case reports of Zika co-infection with chikungunya, dengue-2 and Guillain-Barré - Includes coverage of microcephaly and developmental delays and examines Zika outbreaks in Brazil, Honduras, Uganda, Jamaica and Mozambique
Zika virus (ZIKV) is a mosquito-borne member of the Flaviviridae family that historically has been associated with mild febrile illness. However, the recent outbreaks in Brazil in 2015 and its rapid spread throughout South and Central America and the Caribbean, together with its association with severe neurological disorders—including fetal microcephaly and Guillain-Barré syndrome in adults—have changed the historic perspective of ZIKV. Currently, ZIKV is considered an important public health concern that has the potential to affect millions of people worldwide. The significance of ZIKV in human health and the lack of approved vaccines and/or antiviral drugs to combat ZIKV infection have triggered a global effort to develop effective countermeasures to prevent and/or treat ZIKV infection. In this Special Issue of Viruses, we have assembled a collection of 32 research and review articles that cover the more recent advances on ZIKV molecular biology, replication and transmission, virus–host interactions, pathogenesis, epidemiology, vaccine development, antivirals, and viral diagnosis.
Zika Virus Biology, Transmission, and Pathology: The Neuroscience of Zika provides a detailed introduction to the molecular biology of the Zika virus and its features, transmission, and impact on neurological systems. Designed to better readers' understanding of the Zika virus, this volume features chapters on the immune response, molecular mechanisms, and other areas to better understand underlying pathways. This book has applicability for neuroscientists, neurologists, virologists and anyone working to better understand the evolution and pathogenesis of Zika virus-related conditions. Zika Virus Impact, Diagnosis, Control, and Models: The Neuroscience of Zika examines diagnosis, vaccines, and potential therapy methods for Zika virus syndrome. The book also details the neuroscience of Guillain-Barré syndrome, its effects and neuromuscular rehabilitation. It is designed to help readers better understand detection, therapies for Zika virus, preventative vaccines, diagnosis and associated microcephaly. Chapters on models enable further research and understanding. This book has applicability for neuroscientists, neurologists, virologists and anyone working to better understand the evolution and pathogenesis of Zika virus-related conditions.Zika Virus Biology, Transmission, and Pathology: - Presents the most comprehensive coverage of a broad range of topics related to the neuroscience of Zika, including transmission and virus biology - Contains an abstract, key facts, a mini dictionary of terms, and summary points to aid in understanding in each chapter - Features chapters on Zika vectors and fetal imaging - Includes coverage of microcephaly and developmental delays and examines Zika outbreaks in Brazil, Puerto Rico and India - Discusses unique topics in Zika biology, associated neuro-inflammation, and impacts on neurological systems Zika Virus Impact, Diagnosis, Control, and Models: - Provides a broad range of topics related to the neuroscience of Zika, including its diagnosis, vaccines and therapy - Contains chapter abstracts, key facts, a dictionary of terms and summary points to aid in understanding - Discusses novel and non-pharmacological therapies, Guillain-Barré Syndrome and vaccine development - Features chapters on rat, mouse, and guinea pig models of Zika and case reports of Zika co-infection with chikungunya, dengue-2 and Guillain-Barré - Includes coverage of microcephaly and developmental delays and examines Zika outbreaks in Brazil, Honduras, Uganda, Jamaica and Mozambique
This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity.--Publisher's description.
Japanese encephalitis and West Nile viruses are members of the Japanese encephalitis serological group of the genus Flavivirus and therefore closely related genetically and antigenically. They share a number of properties, including the use of birds as their major wildlife maintenance host and Culicine mosquitoes for transmission, and they are both associated with severe human disease, as well as fatal infections in horses. The emergence of these two viruses, and their well-established propensity to colonise new areas, make it timely to re-examine their ecology, biology, molecular structure, replication and epidemiology, and these therefore provide the focus of this volume.
The only available reference to comprehensively discuss the common and unusual types of rickettsiosis in over twenty years, this book will offer the reader a full review on the bacteriology, transmission, and pathophysiology of these conditions. Written from experts in the field from Europe, USA, Africa, and Asia, specialists analyze specific patho
Zika Virus Biology, Transmission, and Pathways: The Neuroscience of Zika, Volume One provides a detailed introduction to the molecular biology of the Zika virus and its features, transmission, and impact on neurological systems. Designed to better readers' understanding of the Zika virus, this volume features chapters on the immune response, molecular mechanisms, and other areas to better understand underlying pathways. This book has applicability for neuroscientists, neurologists, virologists and anyone working to better understand the evolution and pathogenesis of Zika virus-related conditions. - Presents the most comprehensive coverage of a broad range of topics related to the neuroscience of Zika, including transmission and virus biology - Contains an abstract, key facts, a mini dictionary of terms, and summary points to aid in understanding in each chapter - Features chapters on Zika vectors and fetal imaging - Includes coverage of microcephaly and developmental delays and examines Zika outbreaks in Brazil, Puerto Rico and India - Discusses unique topics in Zika biology, associated neuro-inflammation, and impacts on neurological systems
This book gathers contributions by 39 international specialists on well-known but neglected mosquito-borne diseases. The authors highlight pathogens that are increasingly being spread worldwide by various mosquito species, a situation worsened further by migration and tourism. The book addresses significant agents of diseases like AIDS, dengue, Zika virus, malaria and even cancer, and the risk of transmission via mosquito-related vectors. In addition, it examines important means of preventing the outbreak of related diseases by using insecticides and/or repellents. A particular focus is on the unique and sophisticated mouthparts of bloodsucking species, which allow them to feed on blood in an undisturbed manner, and by means of which agents of disease can enter potential human and animal hosts. In brief, the book provides a broad range of information for a wide readership, including graduates, teachers and researchers in the fields of parasitology, virology, tropical medicine and microbiology, as well as practitioners and healthcare officials.
The objective of this guideline is to provide global, science-informed recommendations on infant feeding in areas of Zika virus transmission. The primary audience of this guideline is health professionals responsible for developing national and local health protocols, especially those related to infant feeding in infancy and early childhood. The primary audience also includes those directly providing care to infants, such as nurses, general medical practitioners, paediatricians, managers of maternal, newborn and child health programmes and relevant personnel in health ministries, in all settings. Lastly, this guideline is also of interest to pregnant or breastfeeding women living or travelling to areas where Zika virus transmission continues. This guideline aims to help WHO Member States and their partners to make science-informed decisions on the appropriate actions in their efforts to achieve the Sustainable Development Goals, the resolutions of the World Health Assembly on infant and young child feeding and the global targets put forward in the comprehensive implementation plan on maternal, infant and young child nutrition, the global strategy for infant and young child feeding and the Zika Strategic Response Plan.
"The presence, or absence, of neglected tropical diseases (NTDs) can be seen as a proxy for poverty and for the success of interventions aimed at reducing poverty. Today, coverage of the public-health interventions recommended by the World Health Organization (WHO) against NTDs may be interpreted as a proxy for universal health coverage and shared prosperity - in short, a proxy for coverage against neglect. As the world's focus shifts from development to sustainable development, from poverty eradication to shared prosperity, and from disease-specific goals to universal health coverage, control of NTDs will assume an important role towards the target of achieving universal health coverage, including individual financial risk protection. Success in overcoming NTDs is a "litmus test" for universal health coverage against NTDs in endemic countries. The first WHO report on NTDs (2010) set the scene by presenting the evidence for how these interventions had produced results. The second report (2013) assessed the progress made in deploying them and detailed the obstacles to their implementation. This third report analyses for the first time the investments needed to achieve the scale up of implementation required to achieve the targets of the WHO Roadmap on NTDs and universal coverage against NTDs. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES presents an investment strategy for NTDs and analyses the specific investment case for prevention, control, elimination and eradication of 12 of the 17 NTDs. Such an analysis is justified following the adoption by the Sixty-sixth World Health Assembly in 2013 of resolution WHA6612 on neglected tropical diseases, which called for sufficient and predictable funding to achieve the Roadmap's targets and sustain control efforts. The report cautions, however, that it is wise investment and not investment alone that will yield success. The report registers progress and challenges and signals those that lie ahead. Climate change is expected to increase the spread of several vector-borne NTDs, notably dengue, transmission of which is directly influenced by temperature, rainfall, relative humidity and climate variability primarily through their effects on the vector. Investments in vector-borne diseases will avoid the potentially catastrophic expenditures associated with their control. The presence of NTDs will thereby signal an early warning system for climate-sensitive diseases. The ultimate goal is to deliver enhanced and equitable interventions to the most marginalized populations in the context of a changing public-health and investment landscape to ensure that all peoples affected by NTDs have an opportunity to lead healthier and wealthier lives."--Publisher's description.